Citation: A. Laupacis et D. Fergusson, The efficacy of technologies to minimise peri-operative allogeneic transfusion, DEV HEMATOL, 33, 1998, pp. 17-36
Authors:
Fratantoni, JC
Sibinga, CTS
Spence, RK
Murphy, W
van Aken, WG
Laupacis, A
de Wolf, JTM
AuBuchon, JP
Lust, A
de Wit, HJC
Tahhan, HR
van Heukelom, LHS
Valeri, CR
Citation: Jc. Fratantoni et al., The clinical setting: How to optimise supportive haemotherapy - Discussion, DEV HEMATOL, 33, 1998, pp. 43-52
Authors:
Schroder, CP
van der Graaf, WTA
Willemse, PHB
Vellenga, E
de Leij, L
Mulder, NH
de Vries, EGE
Citation: Cp. Schroder et al., The impact of haematopoietic growth factors on supportive care in clinicaloncology: With special attention to potential tumour cell contamination inthe stem cell harvest, DEV HEMATOL, 33, 1998, pp. 81-95
Authors:
Valeri, CR
de Wit, HJC
Sibinga, CTS
de Vries, EGE
AuBuchon, JP
Winslow, RM
Boralessa, H
Fratantoni, JC
Middleton, S
de Leij, L
Goodnough, LT
Nicolson, DM
Lust, A
Citation: Cr. Valeri et al., Chemical and biological alternatives - Discussion, DEV HEMATOL, 33, 1998, pp. 123-131
Citation: D. Fergusson et al., The use of technologies to decrease perioperative allogeneic blood transfusion: An international survey of practice, DEV HEMATOL, 33, 1998, pp. 167-174
Citation: Hcjm. Jacobs et Jhf. Falkenburg, Umbilical cord blood as an alternative source of haematopoietic stem cellsfor transplantation, DEV HEMATOL, 33, 1998, pp. 175-181
Citation: Jp. Aubuchon, Cost-effectiveness of conventional and alternative approaches in transfusion practice: The value of decision analysis, DEV HEMATOL, 33, 1998, pp. 215-221
Citation: Jj. Van Rood, Alternative approaches to human blood resources in clinical practice - Proceedings of the Twenty-Second International Symposium on Blood Transfusion,Groningen 1997, organized by the Red Cross Blood Bank Noord Nederland - Foreword, DEV HEMATOL, 33, 1998, pp. XIII-XVI